Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. Read more about Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. Read more about Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. Read more about Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
Innovating Simpler and Less Toxic Frontline Management for Adults With ALL. Read more about Innovating Simpler and Less Toxic Frontline Management for Adults With ALL.
Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer. Read more about Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer.
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. Read more about Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Read more about RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Meeting Exercise Recommendations Is Beneficial for Cancer Survivors. Read more about Meeting Exercise Recommendations Is Beneficial for Cancer Survivors.
Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline. Read more about Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline.
Systemic Therapy for Melanoma: ASCO Guideline Update. Read more about Systemic Therapy for Melanoma: ASCO Guideline Update.
